Device Rhythmia_ep

Rhythmia Mapping System

Payments companies reported to CMS as associated with Rhythmia Mapping System. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$354Kassociated payments (2023-2025)
1,318clinicians with associated payments
1company reporting

By year

2023 $229K
2024 $73K
2025 $53K

Payments reported as associated with Rhythmia Mapping System, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Clinical Cardiac Electrophysiology $279K
Cardiovascular Disease $45K
Internal Medicine $3,378
Family $3,232
Physician Assistant $3,178
Interventional Cardiology $2,985

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Rhythmia Mapping System

These are the largest totals companies reported as associated with Rhythmia Mapping System. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
John Sims Tyler, TX Clinical Cardiac Electrophysiology $25,085.96
Stanislav Weiner Longview, TX Clinical Cardiac Electrophysiology $21,835.96
Marcos Daccarett Boise, ID Clinical Cardiac Electrophysiology $19,415.66
Johan Aasbo Lexington, KY Clinical Cardiac Electrophysiology $16,627.56
Anish Amin Columbus, OH Clinical Cardiac Electrophysiology $11,578.61
Kevin Makati Lutz, FL Cardiovascular Disease $11,353.91
Jose Cuellar Silva Webster, TX Clinical Cardiac Electrophysiology $11,097.56
Michael Manogue Asheville, NC Clinical Cardiac Electrophysiology $8,992.05
Bradley Knight Chicago, IL Clinical Cardiac Electrophysiology $8,499.00
Wilber Su Stanford, CA Cardiovascular Disease $7,982.73

Prescribed Rhythmia Mapping System?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.